ARLO vs BMRN · rev $306.3M vs P/E 40, rev $1.76B
Arlo Technologies (ARLO) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Arlo Technologies (ARLO) is a building products & equipment company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported ARLO revenue for 2026-06-28 was $306.3M. Net income was $17.9M. ARLO currently screens at market cap $1.78B.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ARLO currently screens at market cap $1.78B. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ARLO and BMRN stock pages for the full models.
Not investment advice.